Supplemental material
Journal of Medical Economics
Volume 25, 2022 - Issue 1
Oncology
The relationship between cost and the recommendation, refusal, and discontinuation of treatment for chronic myeloid leukemia and multiple myeloma in Japan: a cross-sectional exploratory survey
Taro Munakataa Market Access, AbbVie GK, Tokyo, Japan
https://orcid.org/0000-0002-8673-0412
https://orcid.org/0000-0002-8673-0412, Yutaka Handab Medical, AbbVie GK, Tokyo, Japanhttps://orcid.org/0000-0002-7800-3258
https://orcid.org/0000-0002-7800-3258, Toru Mizunob Medical, AbbVie GK, Tokyo, Japanhttps://orcid.org/0000-0001-8811-662X
https://orcid.org/0000-0001-8811-662X, Nobuko Tomiuchic Medical Solutions, INTAGE Healthcare Inc., Tokyo, Japanhttps://orcid.org/0000-0001-8708-8882
https://orcid.org/0000-0001-8708-8882, Michael LoPrestid Health Economics and Outcomes Research, INTAGE Healthcare Inc., Tokyo, JapanCorrespondence[email protected]
https://orcid.org/0000-0002-2389-8218
https://orcid.org/0000-0002-2389-8218 & Junichi Shimizub Medical, AbbVie GK, Tokyo, Japanhttps://orcid.org/0000-0001-9078-0968
https://orcid.org/0000-0001-9078-0968Related Research Data
The relationship between cost and the recommendation, refusal, and discontinuation of treatment for chronic myeloid leukemia and multiple myeloma in Japan: a cross-sectional exploratory survey
Source:
Taylor & Francis
Linking provided by
